Watfa Al-Mamari is a developmental pediatrician who established the first developmental pediatric clinics in Oman in 2011. She has worked closely with academic institutions to ensure that developmental pediatrics is included in the curriculum for both undergraduate and postgraduate students. She has a special interest in autism and led the team to establish a national program in Oman to screen children for autism at 18 months of age.
Al-Mamari graduated from Sultan Qaboos University in Muscat, Oman, and later did her residency and fellowship at McGill University in Montreal, Canada.
Watfa Al-Mamari
Developmental pediatrician
Sultan Qaboos University
From this contributor
How one doctor made Oman a leader on autism in the Middle East
Developmental pediatrician Watfa Al-Mamari is building an autism program in Oman from the ground up.
How one doctor made Oman a leader on autism in the Middle East
By
Laura Dattaro
4 February 2020 | 5 min read
Explore more from The Transmitter
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
By
Holly Barker
29 January 2026 | 4 min read
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read